East India Pharmaceutical Works Ltd will market two new drugs, namely Prostalyn and Glucovedic, for the treatment of prostrate gland and diabetes respectively. | |
| While Prostalyn has been developed and patented by the Council of Scientific and Industrial Research (CSIR), Glucovedic has been patented by a US-based company called Ayurvedic Life Ltd. East India Pharmaceuticals has helped both the organistions in conducting research for developing the drugs. |
| |
| The two medicines were formally launched on Tuesday in presence of renowned scientist R A Mashelkar, former director general, CSIR, at the Ramakrishna Institute of Culture in Kolkata. |
| |
| Speaking on the occasion, Mashelkar said the liberalisation of Indian economy paved way research in the field of medicine in India. Earlier, it took more than 15 years and $ 1.5 billion to develop a new drug, now a new drug could be developed in five years. |
| |
| "We must create alternative path and conceptual breakthroughs for creating new products," he said. |
| |
| The future is bright for India, as it has three D's in its favour, viz, democracy, demography and diversity. |
| |
| "All nations must have innovation, passion and compassion. We must create compassionate societies, looking into the problems of the poor while creating a new value system for solving the problems of the poor," he said. |
| |
|
| |
